FibroGen Inc (FGEN)
1.05
+0.03
(+2.94%)
USD |
NASDAQ |
Apr 26, 15:24
FibroGen Shares Outstanding: 98.77M for Jan. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
January 31, 2024 | 98.77M |
December 31, 2023 | 98.77M |
October 31, 2023 | 98.34M |
September 30, 2023 | 98.34M |
July 31, 2023 | 98.21M |
June 30, 2023 | 98.20M |
April 30, 2023 | 97.58M |
April 10, 2023 | 96.70M |
March 31, 2023 | 96.62M |
January 31, 2023 | 94.18M |
December 31, 2022 | 94.17M |
October 31, 2022 | 93.96M |
September 30, 2022 | 93.94M |
July 31, 2022 | 93.74M |
June 30, 2022 | 93.73M |
April 30, 2022 | 93.30M |
April 18, 2022 | 93.29M |
March 31, 2022 | 93.29M |
January 31, 2022 | 93.00M |
December 31, 2021 | 92.88M |
October 31, 2021 | 92.71M |
September 30, 2021 | 92.71M |
July 31, 2021 | 92.62M |
June 30, 2021 | 92.61M |
April 30, 2021 | 92.13M |
Date | Value |
---|---|
March 31, 2021 | 92.08M |
March 29, 2021 | 92.07M |
January 31, 2021 | 91.56M |
December 31, 2020 | 91.44M |
October 31, 2020 | 91.01M |
September 30, 2020 | 90.88M |
July 31, 2020 | 90.36M |
June 30, 2020 | 90.23M |
April 30, 2020 | 89.10M |
April 09, 2020 | 89.07M |
March 31, 2020 | 88.90M |
January 31, 2020 | 88.00M |
December 31, 2019 | 87.66M |
October 31, 2019 | 87.25M |
September 30, 2019 | 87.21M |
July 31, 2019 | 86.92M |
June 30, 2019 | 86.85M |
April 30, 2019 | 86.22M |
April 09, 2019 | 86.15M |
March 31, 2019 | 86.13M |
January 31, 2019 | 85.56M |
December 31, 2018 | 85.43M |
October 31, 2018 | 84.98M |
September 30, 2018 | 84.85M |
July 31, 2018 | 84.33M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
86.22M
Minimum
Apr 30 2019
98.77M
Maximum
Jan 31 2024
92.57M
Average
92.71M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Emergent BioSolutions Inc | 52.20M |
Annovis Bio Inc | 11.01M |
Geron Corp | 546.06M |
Regulus Therapeutics Inc | 65.47M |
Fate Therapeutics Inc | 99.24M |